Nirmatrelvir | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Nirmatrelvir
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Nirmatrelvir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 4 USDMF, 1 EU WC, 3 KDMF, 4 NDC API, 16 Listed Suppliers, $ API Reference Price

23 API Suppliers
4 USDMF
1 EU WC
3 KDMF
4 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

73 Drugs in Development

73 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 1 Europe, 2 Canada, 1 South Africa, 1 Listed Dossiers

5 FDF Dossiers
1 Europe
2 Canada
1 South Africa
1 Listed Dossiers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 3 Stock Recap #PipelineProspector, 133 News #PharmaBuzz

1 Data Compilation #PharmaFlow
3 Stock Recap #PipelineProspector
133 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 1 Regulatory FDF Prices, 4 Annual Reports

2 US Medicaid Prescriptions
1 Regulatory FDF Prices
4 Annual Reports

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

$ API Ref.Price (USD/KG) : 11,187 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Pfizer Canada ULC

filter Patent Reset all filters

2 All

01 23137824

filter Product Reset all filters

2 All

01 2NIRMATRELVIR | RITONAVIR

filter Dosage Reset all filters

2 All

01 2TABLET

filter Exp Date Reset all filters

2 All

01 22041-08-06

Product Main Page

01

Pfizer Canada ULC

Nirmatrelvir, Ritonavir

Peptide Process CMC

Not Confirmed

Pfizer Canada ULC

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-08-06

Date Granted : 2022-11-08

Nirmatrelvir, Ritonavir

Brand Name : PAXLOVID

Patent Number : 3137824

Filing Date : 2021-08-06

Strength per Unit : 150mg / 100mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2041-08-06

Date Granted : 2022-11-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Pfizer Canada ULC

Nirmatrelvir, Ritonavir

Peptide Process CMC

Not Confirmed

Pfizer Canada ULC

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-08-06

Date Granted : 2022-11-08

Nirmatrelvir, Ritonavir

Brand Name : PAXLOVID

Patent Number : 3137824

Filing Date : 2021-08-06

Strength per Unit : 150mg / 100mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2041-08-06

Date Granted : 2022-11-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!